Advancement of therapeutic antibody discovery faces time and economic constraints. Merck R&D experts address this issue using Fluidic Sciences and Sphere Bio's microfluidic picodroplet technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results